VPC
BSX icon

Vestal Point Capital’s Boston Scientific BSX Stock Holding History

Vestal Point Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-800,000
Closed -$50.2M – 73
2026
Q1 		$50.2M Buy
+800,000
New +$64M 1.4% 25

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vestal Point Capital's BSX Position: Q2 2026 in Review

Vestal Point Capital sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 800,000 shares — an estimated $50.2M sold.

Vestal Point Capital first reported a position in BSX in Q1 2026 and held it in 1 quarter. The position peaked at $50.2M in Q1 2026. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Vestal Point Capital reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Vestal Point Capital sold 800,000 Boston Scientific shares in Q2 2026, an estimated $50.2M.
  • Vestal Point Capital first reported a position in Boston Scientific in Q1 2026 and held it in 1 quarter.
  • Vestal Point Capital's Boston Scientific position peaked at $50.2M in Q1 2026.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Vestal Point Capital's 13F filing for Q2 2026, filed 14 Aug 2026.